SOURCE: LED Medical Diagnostics Inc.

LED Medical Diagnostics Inc.

September 30, 2014 08:30 ET

LED Medical Diagnostics Showcases New Digital Imaging Products at American Conferences and Trade Shows

Conferences Provide Ideal Forums for Marketing New Products and Outlining Growth Strategy

BURNABY, BC--(Marketwired - September 30, 2014) - LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or "the Company") has participated in several conferences in the United States in the last few weeks that have raised the Company's profile. These forums have also enabled CEO Dr. David Gane and members of the marketing team to convey information to conference participants about the Company's expanding portfolio of new digital imaging technology products and its future growth strategy. 

"We are delighted to have these opportunities to illustrate the capabilities of our new digital imaging products on a national stage provided by these conferences in the U.S., the largest market for dental imaging products in the world," stated CEO Dr. David Gane. "Raising the profile of our new products at this time of the year is important because most American dentists make the majority of their equipment purchases in the last quarter due to specific tax incentives. We recently issued revenue projections for 2014 which we plan to attain by proactively marketing our products through various initiatives such as the conferences we recently attended."

The conferences that the Company has attended in the past month include the California Dental Association Annual Conference, entitled, "CDA Presents the Art and Science of Dentistry," in San Francisco, California (Sept. 4 to 6), the American Association of Oral and Maxillofacial Surgeons 94th Annual Meeting (AAOMS) in Honolulu, Hawaii (Sept. 8 to 13) and the American Academy (AAP) of Periodontology 100th Annual Meeting and Exhibition in San Francisco, California (Sept. 20 to 22).

The CDA Conference, which was attended by more than 27,000 dental professionals, was one of the first opportunities that LED Medical has had to display the Samsung RAYSCAN Alpha -- Expert to the general dental market. In addition to the RAYSCAN Alpha, a multi-function digital extraoral imaging system with 3D cone beam computed tomography (CBCT), the rest of the new digital imaging technology product line was presented. The Company also had a separate booth for the Velscope® Vx, a hand held medical device used by dentists to conduct screenings for oral cancer and other oral mucosal diseases, where product demonstrations were conducted and sales leads were collected. 

At the AAOMS Annual Meeting, the RAYSCAN Alpha was introduced for the first time to the oral and maxillofacial surgery market. The Company also displayed and demonstrated the Opteo intraoral sensors and the LED IC100 and LED IC200 cameras. 

The AAP Annual Meeting marked the first time that the RAYSCAN Alpha and the Company's other digital imaging products have been presented and demonstrated at a periodontal trade show. A considerable amount of interest was expressed in the RAYSCAN Alpha, the Opteo sensors and both the Company's intraoral cameras. 

LED Medical will be attending several other conferences this year including: 

  • Pacific Coast Society of Orthodontists 78th Session in Anaheim, California (Oct. 3 to 4); 
  • 155th American Dental Association (ADA) Annual Session in San Antonio, Texas (Oct. 9 to 11); 
  • Southwestern Society of Orthodontists Annual Session in Little Rock, Arkansas (Oct. 24 to 25); 
  • Northeastern Society of Orthodontists Annual Meeting in Hartford, Connecticut (Nov. 7 to 8); 
  • Greater New York Dental Meeting in New York City, New York (Nov. 28 to Dec. 4); and 
  • AAMOS Dental Implant Conference in Chicago, Illinois (Dec. 4 to 6).

About LED

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiary LED Dental, provides dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.

The Company is currently listed on the Toronto Stock Exchange (TSX-V) under the symbol "LMD", the OTCQX under the symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME". For more information, call 844.952.7327 or visit www.leddental.com/investor-relations.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements
This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company's future growth strategy, its distribution strategy and product offerings, potential expansion of the Company's technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2013. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Contact Information